Large Clinical Trials Change Experts’ Minds On Prostate Cancer Screening | Latest News RSS feed

Large Clinical Trials Change Experts’ Minds On Prostate Cancer Screening - Latest News


Large clinical trials change experts’ minds on prostate cancer screening

Prostate cancer screening is now something to consider for men aged 55 to 69, according to the federal panel tasked with making recommendations for such preventative care options. In a finalized recom... read more

New FDA-Approved Prostate Cancer Test May Change Screening Landscape

Renowned PSA screening expert ... prostate cancer may then be treated for a cancer that may not have been life-threatening if left undiagnosed or untreated. "Despite these challenges, when studied in ... read more

Prostate-Cancer Screening: Men Should Forgo PSA Testing, Panel Advises

The USPSTF, which in 2009 recommended that women delay routine mammograms until age 50, based its prostate-cancer-screening guidelines on a review of previous research, including two large studies ... ... read more

Looking for another news?


Side effects persist after prostate cancer treatment

And a number of studies have found no proof that using PSA blood tests to screen men for prostate cancer actually saves lives. Because of that the U.S. Preventive Services Task Force (USPSTF) - an exp... read more


Urologists say most men may skip PSA test for prostate cancer

The precise level of PSA in the blood or patterns of PSA change deemed ... evidence from clinical trials instead of the "consensus opinion" of urologists, as was done in the past. The guideline acknow... read more

Overdiagnosis—when finding cancer can do more harm than good

Overdiagnosis is one of the key things to consider when working out the balance of possible benefits and harms of cancer screening. Keep in mind ... A large study from 2013 looked at the results of di... read more

Cardiovascular Toxicity in Cancer Survivors: Current Guidelines and Future Directions

(5) Breast, prostate ... Patients With Breast Cancer Enrolled in SWOG Clinical Trials. J Clin Oncol 2018:Mar 27: [Epub ahead of print]. 16. Aapro M, et al. Anthracycline cardiotoxicity in the elderly ... read more

Nationwide effort aims for more diversity in clinical drug trials

The vast majority are white, a well-documented fact that health care experts ... clinical trial volunteers. An FDA report in 2013 analyzed the disparity in clinical trial participants for specific dis... read more

How One Family Tackled The 'Team Sport' Of Tough Prostate Cancer Choices

My first reaction to the option of active surveillance was "No." "No, no, no. No." A cancer diagnosis without any treatment seemed ludicrous. Even for prostate cancer, known as a sloth in the oncology ... read more

Do 45-Year-Olds Really Need Colon Cancer Screening?

The large ... cancer screening is likely to continue. The question is what should people in the 45 to 49 age range do right now? Bearing in mind that the new ACS guideline is based on no direct clinic... read more

Surgery unneeded for most early-stage prostate cancer, study says

Most patients diagnosed with early-stage prostate cancer ... experts noted. But overall, the clinical trial — the largest of its kind and the first in the era of widespread PSA screening — should be w... read more

Urologists say most men may skip PSA test for prostate cancer

A man with no risk factors for prostate cancer can go ... medical evidence from clinical trials instead of the “consensus opinion” of urologists, as was done in the past. The guideline acknowledges th... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us